Diabetes mellitus (DM) is a major risk factor for cardiovascular disease (CVD) among the general population, and a strong risk factor for CVD in the HIV-infected population. Prediction models for the onset of type II DM in the general population have been developed but have not yet been validated amongst HIV-infected individuals. Our objective is to develop a risk assessment model for the short-term risk of DM for HIV-infected populations following the commencement of combination therapy.
Purpose of the study
Diabetes mellitus (DM) is a major risk factor for cardiovascular disease (CVD) among the general population, and a strong risk factor for CVD in the HIV-infected population. Prediction models for the onset of type II DM in the general population have been developed but have not yet been validated amongst HIV-infected individuals. Our objective is to develop a risk assessment model for the short-term risk of DM for HIV-infected populations following the commencement of combination therapy.
Methods
All patients recruited to D:A:D with follow-up data, without prior DM or MI or other CVD events, and with a complete DM risk factor profile were included. Baseline was defined as the first time point at or after inclusion to the D:A:D study when information on all DM risk factors was available. Data were randomly split, into a training (66%) and validation (34%) data sets. A D:A:D predictive model for the short-term risk of DM was determined in the training dataset using Poisson regression methods. 
